InvestorsHub Logo
Followers 22
Posts 4027
Boards Moderated 1
Alias Born 08/18/2017

Re: None

Tuesday, 07/20/2021 12:25:43 PM

Tuesday, July 20, 2021 12:25:43 PM

Post# of 1587
THC BioMed Releases Third Quarter Results
THC - CSE THCBF - OTC TFHD .F
Vancouver, Canada, June 28, 2021 -- THC BioMed Intl Ltd. (CSE:THC) (“THC BioMed” or the “Company”)
is pleased to report its financial results for the three and nine months ended April 30, 2021.
Q3 HIGHLIGHTS
? Received a letter of authorization from the Autorités des Marchés Publics (“AMP”), Quebec’s Public
Markets Authority providing the authorization as granted by AMP pursuant to Quebec’s Act
Respecting Contracting by Public Bodies and permits THC BioMed to enter into contracts with
Quebec’s Société québécoise du cannabis (“SQDC”). Pursuant to Quebec’s Cannabis Regulation
Act, only the SQDC may purchase cannabis from a federally licensed cannabis producer and sell it
to the public in Quebec. This authorization is just a first step in possibly entering into the Quebec
cannabis market for THC BioMed.
? Completed construction of three strata units, increasing edible and beverage production space and
adding new facilities for baked goods, and submitted the application to Health Canada requesting
clearance to commence production in the newly constructed areas
? Began production of strawberry and orange flavoured THC Kiss Gummies
? Began production of cinnamon, shortbread, and cocoa flavoured THC Kiss Cookies
? Engaged a consultant to carry out an enhancement project on the Company’s automated cannabis
cylinder machine to improve cannabis cylinder production and add automated packaging to the
process. The Company has granted the consultant 500,000 stock options to acquire 500,000
common shares of the Company at $0.165 per share with an expiry date of March 16, 2023. 50,000
stock options vest at the date of grant and the balance pursuant to specific milestones being
attained.
HIGHLIGHTS SUBSEQUENT TO APRIL 30, 2021
? Engaged the services of Toronto-based Oak Hill Financial Inc. to assist with investor relations
activities for a three-month period for a total cost of $24,000 plus the issuance of 300,000 stock
options to acquire 300,000 common shares of the Company at $0.13 per share with an expiry date of
June 9, 2023. The options vest immediately.
? Provided notice that it intends to be qualified to file a short form prospectus under NI 44-101

https://backend.otcmarkets.com/otcapi/company/dns/news/document/51000/content